Providing market intelligence for more than 35 years

In The News

Future-Proofing New Homes

For home builders, home technology ranging from security, safety, comfort, lighting, and environment systems, to appliances, to infotainment, to linkages to others (humans, things, networks, etc.), the prefer-vs.-pay-for debate includes a subtle though powerful third factor, a triangulatior question. Namely, beyond the question of what people say they'd prefer, and what they'd agree to pay for, it's more and more often going to be a question of what they expect.

Parks Associates research director Brett Sappington was on hand this week at our BUILDER Connections event in Dallas, to address some of the " Trend Vs. Fad" questions and observations about home technology and new home design, engineering, and functionality.

One of Sappington's key points was this. Believe it or not, people are not even especially aware when it comes to "smart home" as an offering. Here's Parks' data on people's "familiarity" with the concept.

From the article "Future-Proofing New Homes" by John McManus.

Previously In The News

Are Consumers Right to Fear Connected Home Products?

According to a recent whitepaper by Parks Associates, “72 percent of smart home product owners are concerned with the security of personal data collected by their devices.” From the article, "Are C...

Christmas in July: Cheers to a Healthy New Year!

Currently, 51 percent of U.S. households have at least one connected health device, according to Parks Associates. Consumer awareness about the shift towards care in the home is growing and a new buzz...

Report: Smart Homes are Home Sweet Home for MDUs

Smart home devices are very popular and can contribute mightily to satisfaction with multi dwelling unit living, according to a white paper from Parks Associates and Cox Communities. In July, 2021,...

What Messi's MLS, Apple, Adidas deal means for everyone else

Research by Parks Associates, a market research and consulting company, showed that "annual sports OTT subscription revenue in the United States was $13.1 billion in 2022 and will almost double to app...